Veracyte (VCYT) BidaskScore is downgraded to Sold

Veracyte, Inc.

The BidaskScore of Veracyte Inc VCYTVCYT shows that the shares of the company are now VCYTStrongly Bought Sold by investors.

The BidaskScore of the Health Care EquipmentHealth Care Equipment shows that the sector is Health Care EquipmentStrongly Bought Sold since January 6.

Here are the BidAskScore of other related companies in the Health Care Equipment sector:

Veracyte, Inc. engages in the research, development, and commercialization of diagnostic products. Its portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Veracyte, Inc.

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.